CAS: 116169-18-7 - PN 203-831
Fórmula:C19H19N3O5
InChI:InChI=1/C19H19N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9H,1-5H3
- Sinónimos:
- 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- 4-(4-Benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- Dehydro Isradipine
- Methyl Propan-2-Yl 4-(2,1,3-Benzoxadiazol-4-Yl)-2,6-Dimethylpyridine-3,5-Dicarboxylate
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Isradipine EP Impurity D HCl (Isradipine USP Related Compound A HCl, Dehydro Isradipine HCl) REF: 4Z-I-088CAS: 116169-18-7 | - - - | A consultar | Mar 21 May 24 | |
Dehydro Isradipine REF: TR-D229665CAS: 116169-18-7 | - - - | 160,00 €~565,00 € | Jue 27 Jun 24 | |
Dehydro isradipine REF: 3D-FD20919CAS: 116169-18-7 | Min. 95% | A consultar | Vie 28 Jun 24 |
Isradipine EP Impurity D HCl (Isradipine USP Related Compound A HCl, Dehydro Isradipine HCl)
CAS:116169-18-7
Fórmula:
C19H19N3O5·HCl
Forma y color:
Pale Red Solid
Peso molecular:
369.38 36.46
Ref: 4Z-I-088
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
Dehydro Isradipine
CAS:116169-18-7
Applications The main metabolite of Isradipine. References Tse, F., et al.: Eur. J. Clin. Pharmacol., …
Fórmula:
C19H19N3O5
Forma y color:
Light Yellow
Peso molecular:
369.37
Ref: TR-D229665
1mg | 160,00 € | |
2mg | 236,00 € | |
5mg | 565,00 € |
Entrega estimada en Estados Unidos, el Jueves 27 de Junio de 2024
Dehydro isradipine
CAS:116169-18-7
Dehydro isradipine is a high performance liquid chromatography (HPLC) method for the analysis of isradipine. …
Fórmula:
C19H19N3O5
Pureza:
Min. 95%
Peso molecular:
369.37 g/mol
Ref: 3D-FD20919
1mg | A consultar | |
2mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 28 de Junio de 2024